Back to Search Start Over

Do older people know why they take benzodiazepines? A national French cross‐sectional survey of long‐term consumers

Authors :
Alexandra Jobert
Caroline Victorri-Vigneau
Fanny Feuillet
Marie Grall-Bronnec
Pascale Jolliet
Morgane Rousselet
Edouard-Jules Laforgue
MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE)
Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques
Université de Nantes (UN)-Université de Nantes (UN)
Centre hospitalier universitaire de Nantes (CHU Nantes)
Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques
Source :
International Journal of Geriatric Psychiatry, International Journal of Geriatric Psychiatry, 2020, ⟨10.1002/gps.5307⟩
Publication Year :
2020
Publisher :
Wiley, 2020.

Abstract

International audience; OBJECTIVES: Benzodiazepines and non-benzodiazepine hypnotics (or Z-drugs) (BZD/Z) are widely prescribed for older patients despite major side effects and risks when chronically used. The patient's understanding of the treatment is one of the keys to good adherence. The purpose of the study was to assess the knowledge of BZD/Z treatment among older people who were taking BZD/Z for the long term by studying the concordance between the declared reason for taking BZD/Z and its indication. METHODS: This was a cross-sectional, pharmacoepidemiologic ancillary of a national study. Data were collected through a semi-structured interview. All patients from the main study were included. "Good knowledge" was considered when patients gave an indication for each BZD/Z that was similar to its marketing authorization. Univariate and multivariate analyses were carried out to adequately determine profiles and characterize associations. RESULTS: More than half of the patients (61.6%) had a good knowledge regarding their treatment. The presence of a psychiatric disorder, a mean duration of BZD/Z use of less than 120\,months, a desire to stop treatment, educational status, and number and type of BZD/Z used were significantly associated (P\

Details

ISSN :
10991166 and 08856230
Volume :
35
Database :
OpenAIRE
Journal :
International Journal of Geriatric Psychiatry
Accession number :
edsair.doi.dedup.....a267cd24c9aaffdc4dc8f646af5a05dd